The Non-opioid Pain Treatment Market is expected be around US$ 46.20 Billion by 2028 at a CAGR of 18.5% in the given forecast period.
The key factors that drive the market are growing aging population, effective and easy medications of non opioids drugs for cancer. The availability of sophisticated treatment options and better healthcare facilities have enhanced life expectation around the world.
Millions of people around the globe are in pain. Some experience back pain or chronic headaches; others are recouping from accidents, sports injuries, surgery. Consistently, a large number of prescriptions are written for pain medications many are powerful opioids that can cause severe side effects and reactions and some can also cause addictions.
The global Non-opioid Pain Treatment market is segregated on the basis of Application as Migraine, Multiple sclerosis, Surgical, Arthritis, Epilepsy, Fibromyalgia, Cancer, and Dental. Based on Product the global Non-opioid Pain Treatment market is segmented in Menthol-containing, Omega 3 fatty acid-containing, Botulinum toxins, Medical cannabis, and Capsaicin-derived.
The global Non-opioid Pain Treatment market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Non-opioid Pain Treatment market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Panag Pharma Inc., GW Pharmaceuticals, Medical Marijuana Inc., Aurora, Bedrocan, Canopy Growth Corp., Cara Therapeutics, Allergan PLC, CHT Medical, Cronos Group, and others are among the major players in the global Non-opioid Pain Treatment market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Non-opioid Pain Treatment Market has been segmented as below:
Non-opioid Pain Treatment Market, By Application
Non-opioid Pain Treatment Market, By Product
Non-opioid Pain Treatment Market, By Region
Non-opioid Pain Treatment Market, By Company
The report covers:
Report Scope:
The global Non-opioid Pain Treatment market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Non-opioid Pain Treatment market share. Major industry players with significant revenue share include Panag Pharma Inc., GW Pharmaceuticals, Medical Marijuana Inc., Aurora, Bedrocan, Canopy Growth Corp., Cara Therapeutics, Allergan PLC, CHT Medical, Cronos Group, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate
Below are our new reports:
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Non-opioid Pain Treatment Market, By Application
5.1 Introduction
5.2 Migraine
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Multiple sclerosis
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Surgical
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Arthritis
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Epilepsy
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Fibromyalgia
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Cancer
5.8.1 Market Overview
5.8.2 Market Size and Forecast
5.9 Dental
5.9.1 Market Overview
5.9.2 Market Size and Forecast
6. Non-opioid Pain Treatment Market, By Product
6.1 Introduction
6.2 Menthol-containing
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Omega 3 fatty acid-containing
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Botulinum toxins
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Medical cannabis
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Capsaicin-derived
6.6.1 Market Overview
6.6.2 Market Size and Forecast
7. Non-opioid Pain Treatment Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Non-opioid Pain Treatment, By Application
7.2.2 North America Non-opioid Pain Treatment, By Product
7.3 Europe
7.3.1 Europe Non-opioid Pain Treatment, By Application
7.3.2 Europe Non-opioid Pain Treatment, By Product
7.4 Asia-Pacific
7.4.1 Asia-Pacific Non-opioid Pain Treatment, By Application
7.4.2 Asia-Pacific Non-opioid Pain Treatment, By Product
7.5 Rest of the World
7.5.1 Rest of the World Non-opioid Pain Treatment, By Application
7.5.2 Rest of the World Non-opioid Pain Treatment, By Product
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Panag Pharma Inc.
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 GW Pharmaceuticals
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Medical Marijuana Inc.
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Aurora
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Bedrocan
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Canopy Growth Corp.
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Cara Therapeutics
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Allergan PLC
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 CHT Medical
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Cronos Group
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Non-opioid Pain Treatment Market has been segmented as below:
Non-opioid Pain Treatment Market, By Application
Non-opioid Pain Treatment Market, By Product
Non-opioid Pain Treatment Market, By Region
Non-opioid Pain Treatment Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
